action of semaglutide Exploring beyond numeric weight loss: The metabolic effects Semaglutide-Mediated Remodeling of Adipose Tissue

Robert Kushner, the lead investigator of a huge recent trial, about whether semaglutide really is a game-changing treatment for obesity.

Doctor-led GLP-1 weight-loss treatment with body-composition tracking, health coaching and transparent pricing

GLP-1 treatment that reduces appetite and helps control cravings

Retatrutide is an investigational GLP-1/GIP/glucagon receptor agonist supplied for qualified research into triple-incretin pathway biology

Select Dose: Select the prescribed dose (usually starting at a lower dose and gradually increasing)

A study reveals that semaglutide, an anti-obesity and diabetes medication, could be manufactured for as low as $3 per month after losing patent protection, potentially transforming health care access in low and middle-income countries.